Abb Vie Inc. Reata Pharmaceuticals Inc (RETA) insider trading activity

RETA Quotes by TradingView

Abb Vie Inc. is > 10% Shareholder of REATA PHARMACEUTICALS INC. Currently has a direct ownership of 1.19 Million shares of RETA, which is worth approximately $0. The most recent transaction as insider was on Mar 28, 2017, when has been sold 450,000 shares (Class A Common Stock) at a price of $22.5 per share, resulting in proceeds of $10,125,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.19M
0% 3M change
0% 12M change
Total Value Held $0

AbbVie Inc. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 28 2017
SELL
Open market or private sale
$10,125,000 $22.5 p/Share
450,000 Reduced 27.43%
1,190,473 Class A Common Stock
Feb 02 2017
BUY
Conversion of derivative security
-
1,505,241 Added 47.85%
1,640,473 Class A Common Stock
AI

Abb Vie Inc.

> 10% Shareholder
North Chicago, IL

Track Institutional and Insider Activities on RETA

Follow REATA PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RETA shares.

Notify only if

Insider Trading

Get notified when an Reata Pharmaceuticals Inc insider buys or sells RETA shares.

Notify only if

News

Receive news related to REATA PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RETA